MUC2 and intestinal disorder: As Engevik et al., have recently reported that patients with C. difficile associated intestinal disease exhibit decreased Muc2 and an impaired mucus barrier56, the ability of MFGM supplementation to increase Muc2 levels in the colon may be one mechanism by which MFGM conferred protection in this model.